Eli Lilly CEO's pay falls 9% to $21.5M—no thanks to pension declines

Eli Lilly posted 15% revenue growth last year amid multiple new drug launches, including COVID-19 antibodies. But the drugmaker’s CEO pay didn’t enjoy the same upturn.

Lilly CEO David Ricks collected $21.5 million for his 2021 compensation, down 9% from the $23.7 million he got in 2020, a proxy filing shows.